Chamaecytisus rochelii
Chamaecytisus rochelii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Chamaecytisus rochelii is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Researchers have focused on studying its various extracts to uncover specific therapeutic properties within the plant. Current investigations suggest that these preparations may offer significant benefits in the management of Alzheimer's diseases. Furthermore, the plant demonstrates promising antimalarial and antioxidant activities that support its medicinal value. Emerging evidence also indicates that its bioactive compounds could play a role in addressing symptoms associated with depression.
- Synonyms
- Cytisus Ambiguus · Cytisus Leucanthus Var. Obscurus · 13 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Synonyms
Chamaecytisus rochelii is a taxonomically complex species that is frequently identified by several different names in botanical literature. It is recognized as being synonymous with Chamaecytisus albus subsp. obscurus, illustrating the shifting classifications within its lineage. The plant also shares a taxonomic relationship with Chamaecytisus ambiguus and the specific subspecies Chamaecytisus rochelii subsp. ambiguus. Furthermore, researchers often encounter it under the varietal names Chamaecytisus rochelii var. angustifolius and Chamaecytisus rochelii var. bulgaricus. Navigating these various synonyms is essential for anyone studying the precise genetic and morphological diversity of this shrub.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Chamaecytisus rochelii is a specialized organism belonging to the kingdom Plantae. Within this vast botanical realm, it is classified under the class Equisetopsida. The plant is further organized into the order Fabales, showcasing its specific evolutionary lineage. It falls under the genus Chamaecytisus, which helps scientists identify its unique characteristics. Finally, its membership in the family Fabaceae connects it to a diverse group of well-known flowering plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Chamaecytisus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Chamaecytisus rochelii is a notable plant species with a broad geographic footprint across the European continent. Its presence is well-documented throughout Eastern Europe, specifically within the borders of Ukraine. Moving toward the center of the continent, the species is also commonly found in Middle Europe, including regions such as Hungary. The plant extends its reach into Southeastern Europe, where it thrives in Bulgaria and Romania. Finally, its distribution continues through the Northwestern Balkan Peninsula, marking a diverse ecological range.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Chamaecytisus rochelii is a compact shrub characterized by its low-profile growth form. This resilient plant typically reaches a maximum height of only 1 meter.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Chamaecytisus rochelii, also known through its synonym Cytisus villosus, has been identified as a significant source of bioactive compounds. Research into the aerial parts of this Algerian plant has successfully isolated several key flavonoids. Specifically, the plant contains the important flavonoid genistein. Additionally, chemical analysis confirmed that Chamaecytisus rochelii contains chrysin. These findings highlight the species' potential as a rich source for developing anti-inflammatory and antitrypanosomal agents.
Conditions
Chamaecytisus rochelii exhibits significant potential in treating neurodegenerative conditions such as Alzheimer's and Parkinson's diseases through the inhibition of monoamine oxidases. The plant also demonstrates therapeutic efficacy against the protozoan Trypanosoma brucei. Research indicates that its extracts possess notable anti-inflammatory properties by inhibiting induced nitric oxide synthase. However, the provided abstracts specifically note that the extracts showed no antibacterial activity.
Preparations
Chamaecytisus rochelii is prepared as extracts for scientific investigation. These preparations allow researchers to isolate specific bioactive compounds within the plant. By utilizing such extracts, the medicinal properties of the species can be effectively evaluated. This method of preparation is essential for identifying the chemical constituents responsible for biological activity. Consequently, the use of extracts facilitates a deeper understanding of the plant's potential applications.